Ascendis Pharma A / S announces – GuruFocus.com
- Last-minute oral presentation will include a full 58-week results review of the business phase 2 Path Forward Trial - COPENHAGEN, Denmark, September 30, 2021 (GLOBE NEWSWIRE) - Ascendis Pharma A / S (ASND), a biopharmaceutical company…